Provide feedback
Search
Subscribe
Login
I need to set up an account
Psychiatry
Psychiatry
Conferences
ADHD
Insomnia
More Specialties
Cardiology
Dermatology
Endocrinology
Gastroenterology
Infectious Disease
Internal Medicine
Nephrology
Neurology
Hematology/Oncology
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonary/Respiratory
Rheumatology
Urology
Women's Health
FDA News
Managed Care
FDA lifts hold on Adolor's Entereg in chronic opioid bowel dysfunction; GSK may opt out of agreement for drug in this indication
FDA approves Abbott's Xience V everolimus-eluting stent system for coronary artery disease
In Brief: VioQuest Pharmaceuticals Inc.
FDA advisory committee recommends developers of diabetes drugs include cardiovascular safety, efficacy data
FDA cautions against using protein in cervical spine
Medicare Advantage plans underestimated spending projections in 2005, researchers find
New survey reveals consumer preferences in health care
In Brief: RxHub LLC
In Brief: President Bush
In Brief: Department of Health and Human Services
Home
::
Psychiatry
:: Psychiatry Conferences
AGS 2007 Annual Scientific Meeting
May 2-6, 2007 Seattle, WA
Depression associated with higher discharge-related failure rate, longer length of stay in nursing homes, study suggests
Sleep hygiene may improve sleep for older, hospitalized patients
Insomnia affects many older adults, needs to be treated
Sedating antihistamines often prescribed inappropriately for older adults with insomnia
Cleveland Clinic implements geriatrics rotation for its students
More
APSS SLEEP 2007
June 9-14, 2007 Minneapolis, MN
Insomnia represents potentially large financial liability for employers, research indicates
Patients with insomnia, comorbid depression have more severe insomnia at baseline relative to patients with primary insomnia, other comorbidities
Sublingual transmucosal zolpidem effective, well-tolerated among individuals with MOTN insomnia, findings show
Eszopiclone demonstrates moderate to strong effect sizes on sleep outcomes relative to placebo in patients with primary insomnia, insomnia with comorbidities
New research offers insight into pathophysiology of insomnia, potential targets for treatment
More
APA 2007 Annual Meeting - Insomnia track
May 19-24, 2007 San Diego, CA
Researchers outline strategies to improve recognition, diagnosis, treatment of insomnia
Cognitive behavioral therapy, pharmacologic therapy can effectively manage patients with insomnia, expert panel agrees
NG2-73 reduces latency to persistent sleep in model of transient insomnia, Phase II data show
Zolpidem CR effective for long-term use on as-needed basis among individuals with primary insomnia
Ramelteon safe, effective in treatment of insomnia among women in multiple clinical trials
More
APA 2007 Annual Meeting - ADHD track
May 19-24, 2007 San Diego, CA
Children, adults, patients with substance use disorders can receive appropriate diagnosis, treatment for ADHD
OROS methylphenidate shows benefits in patients with ADHD who have comorbid mood, anxiety disorders, concomitant drug therapy in trial
Personality characteristics among adults with ADHD dependent on substance use disorder, study shows
Experts highlight cognitive symptoms of ADHD, efficacy of available treatments
ADHD associated with high rates of comorbid psychiatric disorders in children, adults of both sexes, studies show
More
U.S. Psychiatric & Mental Health Congress 2007
October 11-14, 2007 Orlando, FL
Guanfacine XR effective, safe in treating ADHD in children, adolescents, researchers report
Improving outcomes in adolescents, adults with ADHD
Lisdexamfetamine improves parent-rated measures of ADHD
AISRS useful in measuring methylphenidate therapy for adults with ADHD
Methylphenidate transdermal system shows similar efficacy in male, female children with ADHD, although males may face greater risk of adverse events
More
AACAP 54th Annual Meeting
October 23-28, 2007 Boston, MA
Childhood ADHD associated with functional deficits in young adulthood, findings suggest
Triple-bead mixed amphetamine salts improves ADHD symptoms in adolescents during 16-hour treatment period, Phase II data indicate
Guanfacine XR does not affect daytime sleepiness, increases evening sleepiness in children, adolescents with ADHD, safety analysis shows
Stigma associated with ADHD prevalent, may affect receptivity to treatment
Lisdexamfetamine beneficial for adults with ADHD, new data indicate
More
Most Read
Most Emailed
AISRS useful in measuring methylphenidate therapy for adults with ADHD
Transdermal methylphenidate effectively treats ADHD, improves quality of life in children who switch from ER methylphenidate, research reveals
Doxepin effective, well tolerated in treatment of insomnia, study data show
Abuse potential with OROS methylphenidate lower than with other methylphenidate formulations
Methylphenidate transdermal system shows similar efficacy in male, female children with ADHD, although males may face greater risk of adverse events
New directions for pharmacologic treatment of insomnia
Researchers outline strategies to improve recognition, diagnosis, treatment of insomnia
Cognitive behavioral therapy, pharmacologic therapy can effectively manage patients with insomnia, expert panel agrees
Children, adults, patients with substance use disorders can receive appropriate diagnosis, treatment for ADHD
OROS methylphenidate shows benefits in patients with ADHD who have comorbid mood, anxiety disorders, concomitant drug therapy in trial